Original Article

Hyperglycemia and Mortality in Elderly Patients with Staphylococcus aureus Bacteremia

Authors: Mazen S. Bader, MD, MPH

Abstract

Objective: To investigate the association between hyperglycemia and in-hospital mortality in elderly patients with Staphylococcus aureus bacteremia (SAB).


Methods: We reviewed the medical records of 135 elderly patients with SAB admitted to two tertiary medical centers from January 2003 until December 2004. Patients were stratified into two groups: those with a 7-day post-SAB mean blood glucose <170 mg/dL and those with a 7-day post-SAB mean blood glucose ≥170 mg/dL. A stepwise logistic regression analysis was performed to determine whether the degree of hyperglycemia was a significant predictor of mortality.


Results: Seventy-four (54.8%) patients had methicillin-resistant Staphylococcus aureusbacteremia. During the follow-up period from admission until discharge, 36 (26.7%) patients died. Twenty-one (21.4%) of 98 patients with a 7-day post-SAB mean blood glucose <170 mg/dL died, while 15 (40.5%) of 37 patients with a 7-day post-SAB mean blood glucose ≥170 mg/dL expired. Multivariate analysis identified 3 independent determinants of death: Simplified Acute Physiology Score (SAPS) score at onset of SAB >45 (OR 5.3, 95% CI{1.8, 15.5}, P = 0.002), a 7-day post-SAB mean blood glucose ≥170 mg/dL (OR 3.3, 95% CI{ 1.2, 9.2}, P = 0.03), and altered mental status at the onset of SAB (OR 7.8, 95% CI{2.5, 23.9}, P= 0.0003).


Conclusions: Hyperglycemia is an important marker of increased mortality among hospitalized elderly patients with SAB.


Key Points


Staphylococcus aureus bacteremia is associated with a high mortality in elderly patients.


* Since hyperglycemia is an important predictor of increased mortality among elderly patients with Staphylococcus aureus bacteremia, good glycemic control with avoiding hypoglycemia should be considered.


* Elderly patients are more likely to be infected with methicillin-resistant Staphylococcus aureus.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Greenberg BM, Atmar RL, Stager CE, et al. Bacteremia in the elderly: predictors of outcome in an urban teaching hospital. J Infect 2005;50:288–295.
 
2. McClelland RS, Fowler VJ, Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs young adult patients: comparison of clinical features and mortality. Arch Intern Med 1999;159:1244–1247.
 
3. Van der Horst IC, Ligtenberg JJ, Bilo HJ, et al. Glucose-insulin-potassium infusion in sepsis and septic shock: no hard evidence yet. Crit Care 2003;7:13–15.
 
4. Hirsch IB. In-patient hyperglycemia: are we ready to treat it yet? J Clin Endocrinol Metab 2002;87:975–977.
 
5. McCowen KC, Malhotra A, Bistrian BR. Endocrine and metabolic dysfunction syndromes in the critically ill. Crit Care Clin 2001;17:107–124.
 
6. Volpi E, Ferrando AA, Yeckel CW, et al. Exogenous amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest 1998;101:2000–2007.
 
7. Fava S, Aquilina O, Azzopardi J, et al. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabet Med 1996;13:80–83.
 
8. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999;22:1827–1831.
 
9. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367.
 
10. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker for in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978–982.
 
11. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553–591.
 
12. Bader M, Hinthorn D, Lai SM, et al. Hyperglycemia and mortality of diabetic patients with candidemia. Diabet Med 2005;22:1252–1257.
 
13. Leibovici L, Yehezkelli Y, Porter A. Influence of diabetes mellitus and glycemic control on the characteristics and outcome of common infections. Diabet Med 1996;13:457–463.
 
14. Rasaiah B. Self-monitoring of the blood glucose level: potential sources of inaccuracy. Can Med Assoc J 1985;132:1357–1361.
 
15. Pozzilli P, Leslie R. Infection and diabetes: mechanisms and prospects for prevention. Diabet Med 1994;11:935–941.
 
16. Rayfield E, Ault M, Keusch G, et al. Infection and diabetes: the case for glucose control. Am J Med1982;72:439–450.
 
17. Alexiewicz JM, Kumar D, Smogorzewski M, et al. Elevated cytosolic calcium and impaired proliferation of B lymphocytes in type II diabetes mellitus. Am J Kidney Dis 1997;30:98–104.
 
18. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10 (Suppl 2):46–52.
 
19. Latham R, Lancaster A, Covington J, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001;22:607–612.
 
20. Ginde AA, Rhee SH, Katz ED. Predictors of outcome in geriatric patients with urinary tract infections. J Emerg Med 2004;27:101–108.
 
21. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449–461.
 
22. Krinsley JS. Association between hyperglycemia and increased mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471–1478.
 
23. van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359–366.